G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1827-1832

  Bache, M ^e   Dunst, J ^e   Wurl P ^b   Frode D ^c   Meye, A ^a   Schmidt, H ^a   Rath, F W ^a   Taubert, H ^a,d  

^a Institute of Pathology   (Germany)

^b Surgical Clinic 1   (Germany)

^c Dermatological Department   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e NONE

Author keywords

Apoptosis; G2 M response; p53; Radiation sensitivity; Sarcoma cell lines

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CLONOGENIC ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; SARCOMA CELL; WESTERN BLOTTING; X IRRADIATION;

APOPTOSIS; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; METAPHASE; NEOPLASM PROTEINS; RADIATION TOLERANCE; SARCOMA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032801666     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lowe SW, Bodis S, Mc Clatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994.
2. Bristow RG, Benchimol S, and Hill RP: The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 40: 197-223, 1996.
3. Kastan MB, Onykekwere D, Sridansky D, Vogelstein B, and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
4. Levine AJ, Momand J, and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
5. Kuerbitz SJ, Plunkett BS, Walsh WV, and Kastan MB: Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992.
6. Michalovitz D, Halevy Q, and Oren M: Conditional inhibition of transformation and of cell proliferation by temperature-sensitive mutant of p53. Cell 62: 671-680, 1990.
7. Stewart N, Hicks GG, Paraskevas F, and Mowat M: Evidence for a second cell cycle block at G2/M by p53. Oncogene 12: 237-245, 1995.
8. Agarwal ML, Agarwal A, Taylor WR, and Stark GR: p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995.
9. Mc Kenna WG, Iliakis G, Weiss MC, Bernhard EJ, and Muschel RJ: Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with oncogenes H-ras and v-myc. Radiat Res 125: 283-287, 1991.
10. Palayoor ST, Macklis RM, Bump EA, and Coleman CN: Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat Res 141: 235-243, 1995.
11. Mc Kenna WG, Bernhard EJ, Markiewicz DA, Rudoltz MS, Maity A, and Muschel R: Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on G2 delay. Oncogene 12: 237-245, 1996.
12. Nagasawa H, Keng P, Harley R, Dahlberg W, and Little JB: Relationship between gamma-ray-induced G2/M delay and cellular radiosensitivity. Int J Radiat Biol 66: 373-379, 1994.
13. Schwartz JL: The role of constitutive and inducible processes in the response of human squamous cell carcinoma cell lines to ionizing radiation. Radiat Res 138 (Suppl 1): S37-39, 1994.
14. Falkvoll KH: The occurrence of apoptosis, abnormal mitoses, cells dying in mitosis and micronuclei in a human melanoma xenograft exposed to single dose irradiation. Strahlentherapie und Onkologie 166: 487-492, 1990.
15. Stephens LC, Kian A, Schultheiss TE, Milas L, and Meyn RE: Apoptosis in irradiated murine tumors. Radiat Res 127: 308-316, 1991.
16. Tauchi H, and Sawada S: Analyses of mitotic cell death caused by radiation in mouse leukaemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure. Int J Radiat Biol 65: 449-455, 1994.
17. Bache M, Dunst J, Würl P, Fröde D, Dietzel M, Meye A, Schmidt H, Rath FW, Wohlrab W, Dralle H, and Taubert H: Radiation induced G2/M block and apoptosis in two human sarcoma cell lines with different p53 gene status. Int J Oncol 11: 993-997, 1997.
18. Meye A, Bache M, Hinze R, Schmidt H, Würl P, Holzhausen HJ, Rath FW, and Taubert H: Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly undifferentiated leiomyosarcoma. Int J Oncol 13: 241-248, 1998.
19. Hollstein M, Sidransky D, Vogelstein B, and Harris CC: P53 mutations in human cancers. Science: 253: 49-53, 1991.
20. Greenblatt MS, Bennett WP, Hollstein M, and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
21. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
22. Clarke AR, Purdie CA, and Harrison DJ:. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
23. Lee JM, and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc. Natl Acad Sci USA 90: 5742-5746, 1993.
24. Lowe SW, Ruley HE, Jacks T, and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
25. Lowe SW, Schmitt EM, Smith SE, Osborne BA and Jacks T: p53 is required for for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
26. O'Connor PM, Jackman J, and Bae I: Characterization of the p53 tumorsuppressor pathway in cell lines of the National Cancer Institute Anticancer Drug Screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57: 4285-4300, 1997.
27. Hawkins DD, Demers GW, and Galloway D: Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56: 892-898, 1996.
28. Servomaa K, Kiuru A, Grenman R, Pekkola-Heino K, Pulkkinen JO, and Rytomaa T: P53 mutations with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Proliferation 29: 219-230, 1996.
29. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, and Galloway DA: Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Med 2: 72-79, 1996.
30. Brachmann DG, Beckett M, Graves D, Haraf D, Vokes E, and Weichselbaum RR: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667-3669, 1993.
31. Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, and Pierotti MA: Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Oncogene 14: 2137-2247, 1997.
32. Sirzen F, Heiden T, Nilsson A, Bergh J, Skog S, and Lewensohn R: Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res 17: 3381-3386, 1997.
33. Kyprianou N, and Rock S et al: Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression. Anticancer Res 18: 897-905, 1998.
34. Meyn RE, Stephens LC, Kian Ang K, Hunter NR, Brock WA, Milas L, and Peters LJ: Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol 64: 583-591, 1993.
35. Stapper NJ, Stuschke M, Sak A, and Stuben G: Radiation-induced apoptosis in human sarcoma and glioma cell lines, Int J Cancer 62: 58-62, 1995.
36. Powel SN, De Frank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, and Friend S: Differential sensitivation of p53(-) and p53(+) cells to caffeine-induced radiosensitivation and override of G2 delay. Cancer Res 55: 1643-1648, 1995.
37. cdc2 kinase. Nature Med 2: 1140-43, 1996.
38. Bracey TS, Williams AC, and Paraskeva C: Inhibition of radiation induced G2 delay potentiates cell death by apoptosis and /or the induction of giant cells with disrupted p53 function. Clin Cancer Res 3: 1371-81, 1997.
39. Aloni-Grinstein R, Schwartz D, and Rotter V: Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO-J 14: 1392-401, 1995.
40. Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD, Galloway DA, Donehower LA, Tainsky MA, and Kaufmann WK: Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55; 1763-1773, 1995.
41. Guillouf C, Rosselli F, Krishnaraju K, Moustacci E, Hoffmann B, and Liebermann DA: p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270, 1995.
42. Schwartz D, Almog N, Peled A, Goldfinger N, and Rotter V: Role of wild type p53 in the G2 phase: regulation of the irradiation-induced delay and DNA repair. Oncogene 15: 2597-2607, 1997.
43. Skladanowski A and Larsen AK: Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M Transition: Implications for gene therapy. Cancer Res 57: 818-823, 1997.
44. Bracley TC, Miller JC, Preece A, and Paraskeva C: Radiation induced apoptosis in human colorectal cell lines can occur in the absence of wildtype p53. Oncogene 10: 2391-2396, 1995.
45. Han Z, Chatterjee D, He DM, Early J, Pantazis P, Wyche JH, Hendrickson EA: Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol Cell Biol 15: 5849-5857, 1995.
46. Arita D, Kambe M, Ishioka C, and Kanamaru R: Induction of p53 independent apoptosis associated with G2/M arrest following DNA damage in human colon cancer cell lines, Jpn J Cancer Res 88: 39-43, 1997.
47. Merritt AJ, Allen TD, Potten CS, and Hickman JA: Apoptosis in small intestinal epithelia from p53-null mice: evidence for delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14: 2759-2766,1997.
48. Taubert H, Schmidt H, Würl P, Hinze R, Meye A, Bache M, Berger D, Holzhausen HJ, Dralle H, and Rath FW: Morphological and molecular characterization of an undifferentiated soft tissue sarcoma cell line and derivative clones. Int J Oncol 11: 521-526, 1997.
49. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CD, Ball A, Thomas M, Gusterson BA, and Cooper CS: Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 5: 1297-1301, 1990.
50. Masuda H, Miller C, Koeffler HP, Battifora H, and Cline MJ: Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84: 7716-7719, 1987.